Silo Pharma (SILO) Net Margin (2019 - 2026)
Silo Pharma (SILO) posted Net Margin of 9137.45% for Q1 2026, down 86.85% sequentially from 4890.33% in Q4 2025, and down 341551.0% YoY from N/an in Q1 2025.
Silo Pharma (SILO) Net Margin (2019 - 2026) Analysis & Trends
Silo Pharma has reported Net Margin for 7 years, with the latest figure at 9137.45% in Q1 2026.
- Quarterly Net Margin fell 341551.0% year-over-year to 9137.45% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6717.4% (down 30613.0% YoY) and the FY2025 annual result came in at 4324.44%, up 109102.0% from the prior year.
- Net Margin retreated to 9137.45% in Q1 2026 per SILO's latest filing, from 4890.33% in the prior quarter.
- Over five years, Net Margin peaked at 3662.47% in Q3 2023 and troughed at 10056.54% in Q1 2023.
- A 4-year average of 6318.01% and a median of 5721.94% in 2025 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 560926 bps in 2024, down 376703 bps in 2024.
- Over 4 years, Net Margin stood at 5833.66% in 2023, then tumbled by 65 bps to 9600.69% in 2024, then jumped by 49 bps to 4890.33% in 2025, then tumbled by 87 bps to 9137.45% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 9137.45%, 4890.33%, and 6160.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 12.09% |
| 10 | Silo Pharma | 2.93 Mn | 2.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,137.45% |
| Dec 31, 2025 | -4,890.33% |
| Sep 30, 2025 | -6,160.54% |
| Jun 30, 2025 | -6,681.24% |
| Mar 31, 2025 | -5,721.94% |
| Dec 31, 2024 | -9,600.69% |
| Sep 30, 2024 | -5,152.92% |
| Jun 30, 2024 | -5,169.37% |
| Mar 31, 2024 | -4,447.28% |
| Dec 31, 2023 | -5,833.66% |
| Sep 30, 2023 | -3,662.47% |
| Jun 30, 2023 | -5,619.70% |
| Mar 31, 2023 | -10,056.54% |
| Jun 30, 2021 | -107.49% |
| Mar 31, 2021 | -3,101.14% |
| Dec 31, 2020 | -854.66% |
| Sep 30, 2020 | -474.84% |
| Jun 30, 2020 | -56,356.45% |
| Mar 31, 2020 | -128,852.04% |
| Dec 31, 2019 | -949.74% |